
U.S. Department of Health & Human Services

National Institutes of Health

NCATS
Return Home Inxight Drugs - Home
- Browse Drugs
- US Approved Drugs
- Marketed Drugs
- Investigational Drugs
- All Substances
- Search
- Structure Search
- Sequence Search
- Downloads
- About
ALEXITOL SODIUM JDN69ZV6XV
Possibly Marketed Outside US Source: UK NHS:Alexitol sodium
Source URL: https://tripod.nih.gov/npc/#Download
ALEXITOL SODIUM JDN69ZV6XV
Possibly Marketed Outside US Source: UK NHS:Alexitol sodium
Source URL: https://tripod.nih.gov/npc/#Download
Details
| Stereochemistry | MIXED |
| Molecular Formula | C6H14O6.CO3.Al.Na.HO |
| Molecular Weight | 309.1593 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 0 / 4 |
| E/Z Centers | 0 |
| Charge | 1 |
SHOW SMILES / InChI
SHOW STEREO... HIDE STEREO... SMILES
[OH-].[Na+].[Al+3].[O-]C([O-])=O.OCC(O)C(O)C(O)C(O)CO
InChI
InChIKey=KFVBMBOOLFSJHV-UHFFFAOYSA-K InChI=1S/C6H14O6.CH2O3.Al.Na.H2O/c7-1-3(9)5(11)6(12)4(10)2-8;2-1(3)4;;;/h3-12H,1-2H2;(H2,2,3,4);;;1H2/q;;+3;+1;/p-3
HIDE SMILES / InChI Approval Year
Unknown
149124 | Name | Type | Language |
| alexitol sodium [INN] | Sources: | | Preferred Name | English |
| ALEXITOL SODIUM | Locators: INN MART. MI WHO-DD Naming Organization: INN Sources: | | Official Name | English |
| SODIUM POLYHYDROXYALUMINIUM MONOCARBONATE HEXITOL COMPLEX | Sources: | | Common Name | English |
| | Brand Name | English |
| ALEXITOL SODIUM [MART.] | Sources: | | Common Name | English |
| Alexitol sodium [WHO-DD] | Source: | | Common Name | English |
| ALEXITOL SODIUM [MI] | Sources: | | Common Name | English |
| | Brand Name | English |
| Code System | Code | Type | Description |
| | 100000139114 Created by admin on Mon Mar 31 20:56:47 GMT 2025 , Edited by admin on Mon Mar 31 20:56:47 GMT 2025 | PRIMARY |
| | JDN69ZV6XV Created by admin on Mon Mar 31 20:56:47 GMT 2025 , Edited by admin on Mon Mar 31 20:56:47 GMT 2025 | PRIMARY |
| | SUB82581 Created by admin on Mon Mar 31 20:56:47 GMT 2025 , Edited by admin on Mon Mar 31 20:56:47 GMT 2025 | PRIMARY |
| | 236340 Created by admin on Mon Mar 31 20:56:47 GMT 2025 , Edited by admin on Mon Mar 31 20:56:47 GMT 2025 | PRIMARY | RxNorm |
| | CHEMBL16105 Created by admin on Mon Mar 31 20:56:47 GMT 2025 , Edited by admin on Mon Mar 31 20:56:47 GMT 2025 | PRIMARY |
| | m8 Created by admin on Mon Mar 31 20:56:47 GMT 2025 , Edited by admin on Mon Mar 31 20:56:47 GMT 2025 | PRIMARY | Merck Index |
| | C169770 Created by admin on Mon Mar 31 20:56:47 GMT 2025 , Edited by admin on Mon Mar 31 20:56:47 GMT 2025 | PRIMARY |
| | 91663271 Created by admin on Mon Mar 31 20:56:47 GMT 2025 , Edited by admin on Mon Mar 31 20:56:47 GMT 2025 | PRIMARY |
| | 66813-51-2 Created by admin on Mon Mar 31 20:56:47 GMT 2025 , Edited by admin on Mon Mar 31 20:56:47 GMT 2025 | PRIMARY |
| | 4990 Created by admin on Mon Mar 31 20:56:47 GMT 2025 , Edited by admin on Mon Mar 31 20:56:47 GMT 2025 | PRIMARY |
| | SUB12770MIG Created by admin on Mon Mar 31 20:56:47 GMT 2025 , Edited by admin on Mon Mar 31 20:56:47 GMT 2025 | PRIMARY |
| | 644634 Created by admin on Mon Mar 31 20:56:47 GMT 2025 , Edited by admin on Mon Mar 31 20:56:47 GMT 2025 | ALTERNATIVE |
ACTIVE MOIETY JDN69ZV6XV

ALEXITOL SODIUM NIH NCATS PRIVACY NOTICE ACCESSIBILITY DISCLAIMER HHS VULNERABILITY DISCLOSURE For language access assistance, contact the NCATS Public Information Officer National Center for Advancing Translational Sciences (NCATS), 6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966 version 1.1